期刊文献+

吡柔比星膀胱灌注预防浅表性膀胱癌术后复发的临床观察 被引量:13

Preventive Effect of Intravesical Instillation of Pirarubicin on Postoperative Recurrence of Superficial bladder Cancer
下载PDF
导出
摘要 目的 :探讨吡柔比星膀胱灌注在预防浅表性膀胱癌术后复发的作用。方法 :28例浅表性膀胱癌患者在TURBt或膀胱部分切除术后 ,应用吡柔比星(0 6g/L)膀胱内灌注 ,保留30min。每周1次 ,连用8周 ,而后每月1次 ,连用10个月。结果 :随访1~2年 ,2例复发 ,无肿瘤复发率92.6 % ,该方法副作用少。结论 :吡柔比星用于浅表性膀胱癌术后膀胱灌注预防复发效果好 ,副作用少 。 Objective:To assess the preventive effect of intravesical instillation of pirarubicin on postoperative recurrence of superficial bladder cancer.Methods:The intravesical instillation of pirarubicin(0.6g/L)was given to28patients with bladder cancer following TURBt or partial cystectomy,once a week for8weeks and subˉsequentally once a month for8months.Results:During the follow-up period of1~2years,the tumor-free recurrence rate was92.6%.This method was of less side effects.Conclusion:The intravesical instillation of pirarubicin is an effective method for the prevention of postoperative recurrence of superficial bladder cancer.
出处 《天津医药》 CAS 北大核心 2003年第3期156-157,共2页 Tianjin Medical Journal
关键词 吡柔比星 膀胱灌注 预防 浅表性膀胱癌 术后复发 临床观察 bladder neoplasms carcinoma doxorubicin perfusion,regional administration,intravesical
  • 相关文献

参考文献7

  • 1王仁顺,莫克俭,周乐友.膀胱移行细胞癌的生物学行为与治疗选择[J].中华泌尿外科杂志,1997,18(6):380-383. 被引量:23
  • 2Setsuko K. Rapid uptake by cultured tumor cells and intracellular behavior of 4' - o- tetrahydropyranyladriamycin. J Antibiot, 1983, 36:312~4.
  • 3Saika T, Tsushima T, Nasu Y, et al. Relationship of intracellular concentration and duration of contamination of pirarubicin and adriamycin in human bladder cancer cell lines and human bladder normal mucosa cell line. Gan To Kagaku Ryoho, 1996, 23(7):905~9.
  • 4Kawamura J, Tochigi H, Obata K, et al. A randomized study of pirarubicin(THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer. Hinyokika Kiyo, 1992, 38(2): 379~ 85.
  • 5叶敏,舒畅,马邦一,陈建华,张良.吡柔比星诱导膀胱癌细胞凋亡的实验研究及预防膀胱癌术后复发的效果[J].中华泌尿外科杂志,2002,23(1):16-18. 被引量:157
  • 6Kuroda K, Ishii N, Fukasawa K, et al. Short-term intravesical instillation of pirarubicin(THP) in prophylactic treatment after transurethral resection of superficial bladder tumor. Hinyokika Kiyo, 1998, 44(8): 547~ 52.
  • 7Yamamoto Y, Nasu Y, Saika T, et al. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer. BJU Int, 2000, 86(7):802~4.

二级参考文献11

  • 1张广健,吴长利,韩瑞发,赵玉干,马腾骧,王广有,王凡.膀胱肿瘤抗药机制的实验研究[J].中华泌尿外科杂志,1996,17(4):203-206. 被引量:26
  • 2李黎明,中华泌尿外科杂志,1994年,15卷,37页
  • 3吴长利,中华泌尿外科杂志,1996年,17卷,207页
  • 4张广健,中华泌尿外科杂志,1996年,17卷,203页
  • 5畅继武,中华泌尿外科杂志,1994年,15卷,405页
  • 6谢晓冬,中华泌尿外科杂志,1994年,15卷,409页
  • 7顾方六,泌尿外科,1993年,464页
  • 8申建成,中华泌尿外科杂志,1992年,13卷,431页
  • 9李庆琪,中华泌尿外科杂志,1991年,12卷,3页
  • 10顾方六 吴阶平.尿路上皮肿瘤临床.泌尿外科[M].济南:山东科学技术出版社,1993.464.

共引文献176

同被引文献54

引证文献13

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部